The influence of RS738409 I148M polymorphism of patatin-like phospholipase domain containing 3 gene on the susceptibility of non-alcoholic fatty liver disease.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
14 May 2021
Historique:
received: 15 06 2020
accepted: 21 04 2021
entrez: 9 6 2021
pubmed: 10 6 2021
medline: 23 6 2021
Statut: ppublish

Résumé

We aimed to elucidate the frequency of polymorphic genotypes and alleles of patatin-like phospholipase domain containing 3 rs738409 polymorphism and its possible associations with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis in a cohort from Turkey.We enrolled 200 patients diagnosed with NAFLD and genotyped for rs738409 I148M polymorphism by real-time polymerase chain reaction, particularly by melting curve analysis. SPSS analysis software was used for statistical significance. Continuous variable values were expressed as mean ± standard deviation. Significant statistical level was chosen as p  = 0.05.Our results demonstrate in a cohort from Turkey that rs738409 C > G polymorphism (I148M) of patatin-like phospholipase domain containing 3 gene is significantly able to affect individuals to have NAFLD in unadjusted regression model.Consistent with the previous studies in other populations, our study group showed a significantly higher risk of having NAFLD in unadjusted regression model but not in the adjusted model indicating that non-genetic factors such as age and sex may be responsible for the association. However, independent studies need to validate our findings with a larger group of NAFLD patients, as well as in different ethnic cohorts.

Identifiants

pubmed: 34106646
doi: 10.1097/MD.0000000000025893
pii: 00005792-202105140-00066
pmc: PMC8133255
doi:

Substances chimiques

Blood Glucose 0
Membrane Proteins 0
Lipase EC 3.1.1.3
adiponutrin, human EC 3.1.1.3

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25893

Informations de copyright

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no funding and conflicts of interest to disclose.

Références

Am J Med. 2000 Jan;108(1):9-13
pubmed: 11059435
World J Hepatol. 2014 Apr 27;6(4):217-25
pubmed: 24799990
Can J Gastroenterol Hepatol. 2018 Aug 29;2018:8543763
pubmed: 30228976
Diabetes. 2001 Aug;50(8):1844-50
pubmed: 11473047
J Lipid Res. 2009 Oct;50(10):2111-6
pubmed: 19738004
Curr Pharm Des. 2013;19(29):5219-38
pubmed: 23394097
J Pediatr Gastroenterol Nutr. 2014 May;58(5):632-6
pubmed: 24345846
J Gastroenterol Hepatol. 2020 Jun;35(6):1057-1064
pubmed: 31677195
Hepatology. 2009 Mar;49(3):791-801
pubmed: 19105205
Cell Metab. 2012 May 2;15(5):691-702
pubmed: 22560221
Clin Chem. 2001 Jan;47(1):81-7
pubmed: 11148181
Hum Mol Genet. 2009 Dec 1;18(23):4669-76
pubmed: 19729411
Int J Obes (Lond). 2012 Feb;36(2):225-32
pubmed: 21556044
J Lipid Res. 2017 Jan;58(1):247-255
pubmed: 27836992
Gut Liver. 2016 May 23;10(3):437-45
pubmed: 26610348
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
J Biol Chem. 2001 Sep 7;276(36):33336-44
pubmed: 11431482
Am J Gastroenterol. 2001 Oct;96(10):2957-61
pubmed: 11693332
J Hepatol. 2014 Jul;61(1):75-81
pubmed: 24607626
Gastroenterology. 2009 Sep;137(3):865-72
pubmed: 19524579
J Lipid Res. 2006 Dec;47(12):2799-807
pubmed: 16971732
World J Gastroenterol. 2014 Sep 28;20(36):12956-80
pubmed: 25278691
Gut Liver. 2016 May 23;10(3):456-63
pubmed: 26419236
Clin Gastroenterol Hepatol. 2020 Apr;18(4):935-944.e3
pubmed: 31419571
Gastroenterology. 2009 May;136(5):1585-92
pubmed: 19208353
J Diabetes Res. 2016;2016:2931985
pubmed: 27123461
Semin Liver Dis. 2011 May;31(2):128-46
pubmed: 21538280
J Hepatol. 2012 Jun;56(6):1356-62
pubmed: 22314430
Nat Genet. 2008 Dec;40(12):1461-5
pubmed: 18820647
Hepatology. 2010 Sep;52(3):894-903
pubmed: 20684021
Scand J Gastroenterol. 2016 Aug;51(8):967-73
pubmed: 27150500
Gastroenterology. 2002 Jul;123(1):134-40
pubmed: 12105842
PLoS One. 2012;7(6):e38322
pubmed: 22719876
Hepatology. 2010 Apr;51(4):1209-17
pubmed: 20373368
J Hepatol. 2009 May;50(5):1035-42
pubmed: 19303161
World J Gastroenterol. 2015 Jul 28;21(28):8605-14
pubmed: 26229402
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1463-1472.e6
pubmed: 27317851
Gastroenterology. 2010 Sep;139(3):836-45, 845.e1
pubmed: 20537997

Auteurs

Hikmet Akkiz (H)

Cukurova University, Medical Faculty, Department of Gastroenterology, Adana.

Emre Taskin (E)

Karabuk University, Medical Faculty, Department of Medical Biology and Genetics, Karabuk.

Umit Karaogullarindan (U)

Cukurova University, Medical Faculty, Department of Gastroenterology, Adana.

Anil Delik (A)

Cukurova University, Faculty of Natural and Applied Science, Department of Biology, Adana.

Sedef Kuran (S)

Cukurova University, Medical Faculty, Department of Gastroenterology, Adana.

Ozlem Kutlu (O)

Sabanci University Nanotechnology Research and Application Center, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH